Recent News

• 09.10.2025 - H.C. Wainwright 27thAnnual Global Investment Conference
• 09.05.2025 - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.21.2025 - Delcath Systems to Participate in Upcoming Investor Conferences
• 08.19.2025 - Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
• 08.06.2025 - Delcath Systems Second Quarter 2025 Earnings Call
• 08.06.2025 - Delcath Systems Reports Second Quarter 2025 Results and Business Highlights
• 07.29.2025 - Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference
• 07.25.2025 - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 07.23.2025 - Delcath Systems to Host Second Quarter 2025 Earnings Call
• 05.22.2025 - Delcath Systems Issues Full Year 2025 Guidance

Recent Filings

• 08.15.2025 - 8-K Current report
• 08.15.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.06.2025 - EX-99.1 EX-99.1
• 08.06.2025 - 8-K Current report
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.22.2025 - 8-K Current report
• 05.22.2025 - EX-99.1 EX-99.1
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities